{"id":"https://openalex.org/W1966708909","doi":"https://doi.org/10.1158/0008-5472.can-07-2395","title":"The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates the Effects of Topoisomerase I Poisons by Suppressing Rad51 Expression in a p53-Dependent Manner","display_name":"The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates the Effects of Topoisomerase I Poisons by Suppressing Rad51 Expression in a p53-Dependent Manner","publication_year":2008,"publication_date":"2008-04-01","ids":{"openalex":"https://openalex.org/W1966708909","doi":"https://doi.org/10.1158/0008-5472.can-07-2395","mag":"1966708909","pmid":"https://pubmed.ncbi.nlm.nih.gov/18381438"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-07-2395","doi":"https://doi.org/10.1158/0008-5472.can-07-2395","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-07-2395","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/7/2312/2591941/2312.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/68/7/2312/2591941/2312.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026962347","display_name":"Grazia Ambrosini","orcid":"https://orcid.org/0000-0002-3051-362X","observed_orcids":["https://orcid.org/0000-0002-3051-362X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grazia Ambrosini","raw_affiliation_strings":["1Laboratory of New Drug Development, Department of Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Laboratory of New Drug Development, Department of Medicine and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061390917","display_name":"Sharon L. Seelman","orcid":"https://orcid.org/0000-0001-8788-1485","observed_orcids":["https://orcid.org/0000-0001-8788-1485"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon L. Seelman","raw_affiliation_strings":["1Laboratory of New Drug Development, Department of Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Laboratory of New Drug Development, Department of Medicine and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006374965","display_name":"Li\u2010Xuan Qin","orcid":"https://orcid.org/0000-0002-9367-3807","observed_orcids":["https://orcid.org/0000-0002-9367-3807"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li-Xuan Qin","raw_affiliation_strings":["2Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":["1Laboratory of New Drug Development, Department of Medicine and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Laboratory of New Drug Development, Department of Medicine and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5839,"has_fulltext":true,"cited_by_count":49,"citation_normalized_percentile":{"value":0.8937363,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"68","issue":"7","first_page":"2312","last_page":"2320"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.17299999296665192,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.015399999916553497,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flavopiridol","display_name":"flavopiridol","score":1.0},{"id":"https://openalex.org/keywords/topoisomerase-i-poisons","display_name":"topoisomerase I poisons","score":0.8700000047683716},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.9259999990463257},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9509999752044678},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9169999957084656},{"id":"https://openalex.org/keywords/rad51","display_name":"RAD51","score":0.9990000128746033},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.953000009059906},{"id":"https://openalex.org/keywords/cdk9","display_name":"CDK9","score":0.6959999799728394},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6119999885559082},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6909999847412109},{"id":"https://openalex.org/keywords/gamma-h2ax","display_name":"\u03b3H2AX","score":0.9049999713897705},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.6010000109672546},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5460000038146973},{"id":"https://openalex.org/keywords/p53-ser15-phosphorylation","display_name":"p53 Ser15 phosphorylation","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.8531901836395264},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6081216335296631},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5980973839759827},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5793929696083069},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5276074409484863},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5048766732215881},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4875173270702362},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4513515532016754},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.45056429505348206},{"id":"https://openalex.org/C2778437423","wikidata":"https://www.wikidata.org/wiki/Q5198265","display_name":"Cyclin B1","level":5,"score":0.4476258158683777},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.4406805634498596},{"id":"https://openalex.org/C2778616834","wikidata":"https://www.wikidata.org/wiki/Q281044","display_name":"Topoisomerase inhibitor","level":4,"score":0.4312753975391388},{"id":"https://openalex.org/C120089663","wikidata":"https://www.wikidata.org/wiki/Q59250999","display_name":"Cyclin","level":4,"score":0.4129171073436737},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32784777879714966},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.32219141721725464},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2685765027999878},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.26317182183265686},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.2592911720275879},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.226336270570755},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11467912793159485},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07520857453346252}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042863","descriptor_name":"Cyclin-Dependent Kinase 9","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D045325","descriptor_name":"HCT116 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051135","descriptor_name":"Rad51 Recombinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051135","descriptor_name":"Rad51 Recombinase","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051135","descriptor_name":"Rad51 Recombinase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-07-2395","doi":"https://doi.org/10.1158/0008-5472.can-07-2395","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-07-2395","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/7/2312/2591941/2312.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:18381438","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18381438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-07-2395","doi":"https://doi.org/10.1158/0008-5472.can-07-2395","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-07-2395","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/7/2312/2591941/2312.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7205842776","display_name":"Clinical Trials of Flavopiridol with Chemotherapy","funder_award_id":"R01CA067819","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1966708909.pdf","grobid_xml":"https://content.openalex.org/works/W1966708909.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1599861993","https://openalex.org/W1795529600","https://openalex.org/W1943486034","https://openalex.org/W1959988533","https://openalex.org/W1973125687","https://openalex.org/W1974355172","https://openalex.org/W1992101827","https://openalex.org/W2017782528","https://openalex.org/W2017898416","https://openalex.org/W2020813760","https://openalex.org/W2024124003","https://openalex.org/W2025613035","https://openalex.org/W2029529223","https://openalex.org/W2036179093","https://openalex.org/W2040331457","https://openalex.org/W2045892846","https://openalex.org/W2047697085","https://openalex.org/W2052090116","https://openalex.org/W2053822327","https://openalex.org/W2061335015","https://openalex.org/W2065644280","https://openalex.org/W2074699503","https://openalex.org/W2080411064","https://openalex.org/W2081098333","https://openalex.org/W2081567150","https://openalex.org/W2081581449","https://openalex.org/W2089574530","https://openalex.org/W2097555718","https://openalex.org/W2099763989","https://openalex.org/W2101528503","https://openalex.org/W2109458089","https://openalex.org/W2118564448","https://openalex.org/W2122254308","https://openalex.org/W2128370098","https://openalex.org/W2136682666","https://openalex.org/W2141332502","https://openalex.org/W2141972206","https://openalex.org/W2148810752","https://openalex.org/W2149269236","https://openalex.org/W2155443367","https://openalex.org/W2155640249","https://openalex.org/W2170302386","https://openalex.org/W2170989872","https://openalex.org/W2423510330"],"related_works":["https://openalex.org/W1959988533","https://openalex.org/W2101859810","https://openalex.org/W2099640389","https://openalex.org/W2166474436","https://openalex.org/W2147840403","https://openalex.org/W2119467381","https://openalex.org/W2019067973","https://openalex.org/W1999042332","https://openalex.org/W2130656609","https://openalex.org/W4321429133"],"abstract_inverted_index":{"The":[0],"results":[1],"of":[2,8,80,85,92,111,136,158,165,183,188,193,209,223,227,250,255],"a":[3,119,161,186,247],"phase":[4],"I":[5,11,240],"clinical":[6,44],"trial":[7],"the":[9,18,42,54,77,90,98,103,132,218],"topoisomerase":[10],"(Topo":[12],"I)":[13],"poison":[14],"CPT-11":[15],"followed":[16,87],"by":[17,88,147,167,211,214,238],"cyclin-dependent":[19],"kinase":[20],"inhibitor":[21],"flavopiridol":[22,148,202,219,242],"in":[23,60,97,124,150,160,230,253],"patients":[24,31],"with":[25,102,117,181,221],"advanced":[26],"solid":[27],"tumors":[28,33],"indicate":[29],"that":[30,66,207],"whose":[32],"were":[34,67],"wild-type,":[35],"but":[36],"not":[37],"mutant,":[38],"for":[39,57,74],"p53":[40,112],"obtained":[41],"most":[43],"benefit":[45],"from":[46,198],"this":[47,58],"combination":[48,78,137],"therapy.":[49],"We":[50],"elected":[51],"to":[52,129,178],"elucidate":[53],"mechanistic":[55],"basis":[56],"effect":[59],"isogenic-paired":[61],"HCT116":[62],"colon":[63],"cancer":[64],"cells":[65,100,177,197],"either":[68],"wild-type":[69],"(+/+)":[70],"or":[71,213],"null":[72],"(-/-)":[73],"p53.":[75],"With":[76],"therapy":[79],"SN-38":[81],"(the":[82],"active":[83],"metabolite":[84],"CPT-11)":[86],"flavopiridol,":[89],"induction":[91,226],"apoptosis":[93,180,228],"was":[94,141],"5-fold":[95],"greater":[96],"p53+/+":[99,151,174,196,231],"compared":[101],"p53-/-":[104,176],"cells.":[105,152,232],"This":[106],"sequential":[107],"treatment":[108],"induced":[109],"phosphorylation":[110],"at":[113,144],"Ser(15),":[114],"which":[115],"interacted":[116],"Rad51,":[118,251],"DNA":[120,189,236],"repair":[121],"protein":[122],"involved":[123],"homologous":[125,244],"recombination.":[126],"Rad51":[127,159,166,194,224],"bound":[128],"p53-Ser(15)":[130],"within":[131],"first":[133],"5":[134],"hours":[135,146],"therapy,":[138],"and":[139,175,225],"then":[140],"transcriptionally":[142],"suppressed":[143],"24":[145],"only":[149,229],"Microarray":[153],"analysis":[154],"also":[155],"revealed":[156],"suppression":[157,222],"p53-dependent":[162,248],"manner.":[163],"Depletion":[164],"small":[168],"interfering":[169],"RNA":[170],"(siRNA)":[171],"sensitized":[172],"both":[173],"SN-38-induced":[179],"increase":[182],"gamma":[184],"H2AX,":[185],"marker":[187],"damage.":[190],"Conversely,":[191],"overexpression":[192],"rescued":[195],"SN-->F-induced":[199],"apoptosis.":[200,256],"Because":[201],"inhibits":[203],"Cdk9,":[204],"we":[205],"found":[206],"inhibition":[208],"Cdk9":[210],"DRB":[212],"siRNA":[215],"could":[216],"recapitulate":[217],"effects,":[220],"In":[233],"conclusion,":[234],"after":[235],"damage":[237],"Topo":[239],"poisons,":[241],"targets":[243],"recombination":[245],"through":[246],"down-regulation":[249],"resulting":[252],"enhancement":[254]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}